{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "ARCHITECT\u00ae",
      "COVID-19",
      "Immunoassay",
      "Reverse transcription (RT)-PCR",
      "SARS-CoV-2 IgG",
      "Sensitivity",
      "Specificity"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34108284",
  "DateCompleted": {
    "Year": "2021",
    "Month": "06",
    "Day": "16"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "04",
    "Day": "23"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.3343/alm.2021.41.6.568"
    ],
    "Journal": {
      "ISSN": "2234-3814",
      "JournalIssue": {
        "Volume": "41",
        "Issue": "6",
        "PubDate": {
          "Year": "2021",
          "Month": "Nov",
          "Day": "01"
        }
      },
      "Title": "Annals of laboratory medicine",
      "ISOAbbreviation": "Ann Lab Med"
    },
    "ArticleTitle": "Combination of a SARS-CoV-2 IgG Assay and RT-PCR for Improved COVID-19 Diagnosis.",
    "Pagination": {
      "StartPage": "568",
      "EndPage": "576",
      "MedlinePgn": "568-576"
    },
    "Abstract": {
      "AbstractText": [
        "Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is generally diagnosed by reverse transcription (RT)-PCR or serological assays. The SARS-CoV-2 viral load decreases a few days after symptom onset. Thus, the RT-PCR sensitivity peaks at three days after symptom onset (approximately 80%). We evaluated the performance of the ARCHITECT<sup>\u00ae</sup> SARS-CoV-2 IgG assay (henceforth termed IgG assay; Abbott Laboratories, Lake County, IL, USA), and the combination of RT-PCR and the IgG assay for COVID-19 diagnosis.",
        "In this retrospective study, 206 samples from 70 COVID-19 cases at two hospitals in Tokyo that were positive using RT-PCR were used to analyze the diagnostic sensitivity. RT-PCR-negative (N=166), COVID-19-unrelated (N=418), and Japanese Red Cross Society (N=100) samples were used to evaluate specificity.",
        "Sensitivity increased daily after symptom onset and exceeded 84.4% after 10 days. Specificity ranged from 98.2% to 100% for samples from the three case groups. Seroconversion was confirmed from 9 to 20 days after symptom onset in 18 out of 32 COVID-19 cases with multiple samples and from another case with a positive result in the IgG assay for the first available sample.",
        "The combination of RT-PCR and IgG assay improves the robustness of laboratory diagnostics by compensating for the limitations of each method."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-9237-1217"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan."
          }
        ],
        "LastName": "Aoki",
        "ForeName": "Kotaro",
        "Initials": "K"
      },
      {
        "Identifier": [
          "0000-0001-7062-7229"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Research and Development, Abbott Japan LLC, Chiba, Japan."
          }
        ],
        "LastName": "Takai",
        "ForeName": "Kunitomo",
        "Initials": "K"
      },
      {
        "Identifier": [
          "0000-0002-8070-9102"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan."
          }
        ],
        "LastName": "Nagasawa",
        "ForeName": "Tatsuya",
        "Initials": "T"
      },
      {
        "Identifier": [
          "0000-0002-9523-7689"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "General Medicine and Emergency Center (Internal Medicine), Toho University Omori Medical Center, Tokyo, Japan."
          }
        ],
        "LastName": "Kashiwagi",
        "ForeName": "Katsuhito",
        "Initials": "K"
      },
      {
        "Identifier": [
          "0000-0002-1433-0276"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of General Internal Medicine and Infectious Diseases, National Hospital Organization Tokyo Medical Center, Tokyo, Japan."
          }
        ],
        "LastName": "Mori",
        "ForeName": "Nobuaki",
        "Initials": "N"
      },
      {
        "Identifier": [
          "0000-0002-8361-0167"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan."
          }
        ],
        "LastName": "Matsubayashi",
        "ForeName": "Keiji",
        "Initials": "K"
      },
      {
        "Identifier": [
          "0000-0002-4660-6839"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan."
          }
        ],
        "LastName": "Satake",
        "ForeName": "Masahiro",
        "Initials": "M"
      },
      {
        "Identifier": [
          "0000-0001-9735-3379"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Research and Development, Abbott Japan LLC, Chiba, Japan."
          }
        ],
        "LastName": "Tanaka",
        "ForeName": "Ippei",
        "Initials": "I"
      },
      {
        "Identifier": [
          "0000-0003-1396-6720"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Clinical Laboratory, Toho University Omori Medical Center, Tokyo, Japan."
          }
        ],
        "LastName": "Kodama",
        "ForeName": "Nanae",
        "Initials": "N"
      },
      {
        "Identifier": [
          "0000-0001-7654-0482"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Clinical Laboratory, Toho University Omori Medical Center, Tokyo, Japan."
          }
        ],
        "LastName": "Shimodaira",
        "ForeName": "Takahiro",
        "Initials": "T"
      },
      {
        "Identifier": [
          "0000-0002-1943-4648"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan."
          }
        ],
        "LastName": "Ishii",
        "ForeName": "Yoshikazu",
        "Initials": "Y"
      },
      {
        "Identifier": [
          "0000-0001-7239-8677"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "General Medicine and Emergency Center (Internal Medicine), Toho University Omori Medical Center, Tokyo, Japan."
          }
        ],
        "LastName": "Miyazaki",
        "ForeName": "Taito",
        "Initials": "T"
      },
      {
        "Identifier": [
          "0000-0002-4865-5124"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Clinical Laboratory, Toho University Omori Medical Center, Tokyo, Japan."
          }
        ],
        "LastName": "Ishii",
        "ForeName": "Toshiaki",
        "Initials": "T"
      },
      {
        "Identifier": [
          "0000-0002-5781-4000"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Laboratory Medicine, Toho University School of Medicine, Tokyo, Japan."
          }
        ],
        "LastName": "Morita",
        "ForeName": "Toshisuke",
        "Initials": "T"
      },
      {
        "Identifier": [
          "0000-0002-9178-9777"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Research and Development, Abbott Japan LLC, Chiba, Japan."
          }
        ],
        "LastName": "Yoshimura",
        "ForeName": "Toru",
        "Initials": "T"
      },
      {
        "Identifier": [
          "0000-0002-6200-6163"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan."
          }
        ],
        "LastName": "Tateda",
        "ForeName": "Kazuhiro",
        "Initials": "K"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Korea (South)",
    "MedlineTA": "Ann Lab Med",
    "NlmUniqueID": "101571172",
    "ISSNLinking": "2234-3806"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Viral"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Immunoglobulin G"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Viral"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Reagent Kits, Diagnostic"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "analysis"
      ],
      "DescriptorName": "Antibodies, Viral"
    },
    {
      "QualifierName": [
        "diagnosis",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Testing"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "analysis"
      ],
      "DescriptorName": "Immunoglobulin G"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Longitudinal Studies"
    },
    {
      "QualifierName": [
        "analysis",
        "metabolism"
      ],
      "DescriptorName": "RNA, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Reagent Kits, Diagnostic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Retrospective Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Reverse Transcriptase Polymerase Chain Reaction"
    },
    {
      "QualifierName": [
        "genetics",
        "immunology",
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sensitivity and Specificity"
    }
  ],
  "CoiStatement": "<b>CONFLICTS OF INTEREST</b>. Takai K, Tanaka I, and Yoshimura T are employees of Abbott. The other authors have no conflicts of interest to declare."
}